Scientists confront a bird flu mystery

Also: Among many drug developers and providers seeking to deliver radiopharmaceuticals to patients, there is a lack of expertise

December 2, 2024 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | 'Significant talent shortage' threatens the rise of radiopharmaceuticals Among many drug developers and providers seeking to deliver radiopharmaceuticals to patients, there is a lack of expertise in the burgeoning field. By Allison DeAngelis STAT+ | Novartis to pay $1 billion upfront to license Huntington's drug from PTC Novartis, which has previously tried to develop a Huntington's treatment, is licensing an experimental drug from PTC. By Andrew Joseph STAT+ | Big restaurant chains get an 'F' for antibiotic use in their meat supplies "Antibiotic resistance and the spread of superbugs is getting worse," said Steve Roach of Food Animal Concerns Trust. By Ed Silverman PHILIP FONG/AFP via Getty Images Scientists confront a mystery: Why have U.S. bird flu cases been so mild? For more than two decades, H5N1 has had a well-earned reputation as a very dangerous virus. Fortunately, the current outbreak has proven to be an exception. By Helen Branswell STAT+ | How often 'value-based care' is uttered on Wall Street This week in health care news: Insurers tout value based care, we round up hospital finances, and regulators have an eye on vertical integration. By Bob Herman Despite probe, China reimbursing AstraZeneca drug Today's biotech news has a $1 billion Novartis deal, a reimbursement for AstraZeneca, and concerns from Scott Gottlieb. By Meghana Keshavan Eduardo Munoz Alvarez/Getty Images STAT+ | Supreme Court tackles case involving FDA's oversight of flavored vapes If the FDA loses, the agency could decide to release fewer guidance documents, which give companies insight into its thinking. By Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser